202 related articles for article (PubMed ID: 29952832)
1. Update on amino acid PET of brain tumours.
Langen KJ; Galldiks N
Curr Opin Neurol; 2018 Aug; 31(4):354-361. PubMed ID: 29952832
[TBL] [Abstract][Full Text] [Related]
2. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N
Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264
[TBL] [Abstract][Full Text] [Related]
3. Advances in neuro-oncology imaging.
Langen KJ; Galldiks N; Hattingen E; Shah NJ
Nat Rev Neurol; 2017 May; 13(5):279-289. PubMed ID: 28387340
[TBL] [Abstract][Full Text] [Related]
4. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
5. [German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids].
Langen KJ; Bartenstein P; Boecker H; Brust P; Coenen HH; Drzezga A; Grünwald F; Krause BJ; Kuwert T; Sabri O; Tatsch K; Weber WA; Schreckenberger M
Nuklearmedizin; 2011; 50(4):167-73. PubMed ID: 21789338
[TBL] [Abstract][Full Text] [Related]
6. Role of amino-tracer PET for decision-making in neuro-oncology.
Suchorska B; Albert NL; Tonn JC
Curr Opin Neurol; 2018 Dec; 31(6):720-726. PubMed ID: 30239359
[TBL] [Abstract][Full Text] [Related]
7. Applications of PET imaging of neurological tumors with radiolabeled amino acids.
Galldiks N; Langen KJ
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):70-82. PubMed ID: 25517079
[TBL] [Abstract][Full Text] [Related]
8. Value of 11C-methionine PET in imaging brain tumours and metastases.
Glaudemans AW; Enting RH; Heesters MA; Dierckx RA; van Rheenen RW; Walenkamp AM; Slart RH
Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):615-35. PubMed ID: 23232505
[TBL] [Abstract][Full Text] [Related]
9. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
[TBL] [Abstract][Full Text] [Related]
10. Advantages and limitations of amino acid PET for tracking therapy response in glioma patients.
Langen KJ; Heinzel A; Lohmann P; Mottaghy FM; Galldiks N
Expert Rev Neurother; 2020 Feb; 20(2):137-146. PubMed ID: 31829748
[No Abstract] [Full Text] [Related]
11. Recent Developments of 18F-FET PET in Neuro-oncology.
Muoio B; Giovanella L; Treglia G
Curr Med Chem; 2018; 25(26):3061-3073. PubMed ID: 29173147
[TBL] [Abstract][Full Text] [Related]
12. PET with radiolabeled aminoacid.
Crippa F; Alessi A; Serafini GL
Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):151-62. PubMed ID: 22617237
[TBL] [Abstract][Full Text] [Related]
13. Applications of positron emission tomography in neuro-oncology: a clinical approach.
Demetriades AK; Almeida AC; Bhangoo RS; Barrington SF
Surgeon; 2014 Jun; 12(3):148-57. PubMed ID: 24629841
[TBL] [Abstract][Full Text] [Related]
14. Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [
Piccardo A; Albert NL; Borgwardt L; Fahey FH; Hargrave D; Galldiks N; Jehanno N; Kurch L; Law I; Lim R; Lopci E; Marner L; Morana G; Young Poussaint T; Seghers VJ; Shulkin BL; Warren KE; Traub-Weidinger T; Zucchetta P
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3852-3869. PubMed ID: 35536420
[TBL] [Abstract][Full Text] [Related]
15. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
16. PET imaging in patients with brain metastasis-report of the RANO/PET group.
Galldiks N; Langen KJ; Albert NL; Chamberlain M; Soffietti R; Kim MM; Law I; Le Rhun E; Chang S; Schwarting J; Combs SE; Preusser M; Forsyth P; Pope W; Weller M; Tonn JC
Neuro Oncol; 2019 May; 21(5):585-595. PubMed ID: 30615138
[TBL] [Abstract][Full Text] [Related]
17. Role of amino-acid PET in high-grade gliomas: limitations and perspectives.
Verger A; Arbizu J; Law I
Q J Nucl Med Mol Imaging; 2018 Sep; 62(3):254-266. PubMed ID: 29696948
[TBL] [Abstract][Full Text] [Related]
18. Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.
Hutterer M; Ebner Y; Riemenschneider MJ; Willuweit A; McCoy M; Egger B; Schröder M; Wendl C; Hellwig D; Grosse J; Menhart K; Proescholdt M; Fritsch B; Urbach H; Stockhammer G; Roelcke U; Galldiks N; Meyer PT; Langen KJ; Hau P; Trinka E
J Nucl Med; 2017 Jan; 58(1):129-137. PubMed ID: 27469356
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?
Moulin-Romsée G; D'Hondt E; de Groot T; Goffin J; Sciot R; Mortelmans L; Menten J; Bormans G; Van Laere K
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2082-7. PubMed ID: 17763978
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]